Keunok Jung

Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapy.

Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapy.

Journal: Cancer communications (London, England)
Published: May 31, 2023

Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy.

Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy.

Journal: Frontiers in immunology
Published: September 02, 2022

VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity.

VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity.

Journal: Biochemical and biophysical research communications
Published: August 04, 2022

Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy.

Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy.

Journal: Molecular cancer
Published: December 19, 2021

Affinity Maturation of a T-Cell Receptor-Like Antibody Specific for a Cytomegalovirus pp65-Derived Peptide Presented by HLA-A*02:01.

Affinity Maturation of a T-Cell Receptor-Like Antibody Specific for a Cytomegalovirus pp65-Derived Peptide Presented by HLA-A*02:01.

Journal: International journal of molecular sciences
Published: February 01, 2021

Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity.

Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity.

Journal: Frontiers in immunology
Published: August 11, 2020

Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity.

Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity.

Journal: Scientific reports
Published: March 08, 2019

A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.

A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.

Journal: Cancer immunology research
Published: February 28, 2019

Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells.

Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells.

Journal: Oncoimmunology
Published: September 28, 2017

Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration.

Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration.

Journal: Nature communications
Published: September 02, 2016

Endogenous VSIG4 negatively regulates the helper T cell-mediated antibody response.

Endogenous VSIG4 negatively regulates the helper T cell-mediated antibody response.

Journal: Immunology letters
Published: February 21, 2015

Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma.

Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma.

Journal: Immunology letters
Published: September 17, 2013
Showing 1-12 of 14

Last Updated: 09/26/2026